Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)*
Jodi M. Smith,
Donald M. Stablein, Ricardo Munoz, Diane Hebert,
Ruth A. McDonald,
Jodi M. Smith
Department of Pediatrics, University of Washington, Seattle, WA, USA
Search for more papers by this authorDiane Hebert
Department of Pediatrics, University of Toronto, Toronto, Canada
Search for more papers by this authorRuth A. McDonald
Department of Pediatrics, University of Washington, Seattle, WA, USA
Search for more papers by this authorJodi M. Smith,
Donald M. Stablein, Ricardo Munoz, Diane Hebert,
Ruth A. McDonald,
Jodi M. Smith
Department of Pediatrics, University of Washington, Seattle, WA, USA
Search for more papers by this authorDiane Hebert
Department of Pediatrics, University of Toronto, Toronto, Canada
Search for more papers by this authorRuth A. McDonald
Department of Pediatrics, University of Washington, Seattle, WA, USA
Search for more papers by this authorJodi M. Smith, Department of Pediatrics, University of Washington, Seattle, WA, USATel.: +206-987-2524Fax: +206-987-2636E-mail: [email protected]
*
The North American Pediatric Renal Trials and Cooperative Studies (NAPRTCS) is supported by unrestricted educational grants from Novartis, AMGEN, and Genentech. The NAPRTCS is a voluntary collaborative effort comprising 150 pediatric renal disease treatment centers in the USA, Canada, Mexico, and Costa Rica.
Abstract
Abstract: This summary of the NAPRTCS 2006 Annual Report of the Transplant Registry highlights the significant impact the registry has had in advancing knowledge in pediatric renal transplantation worldwide. This cooperative group has collected clinical information on children undergoing a renal transplantation since 1987 and now includes over 150 participating medical centers in the USA, Canada, Mexico, and Costa Rica. Currently, the NAPRTCS transplant registry includes information on 9837 renal transplants in 8990 patients (NAPRTCS 2006 Annual Report). Since the first data analysis in 1989, NAPRTCS reports have documented marked improvements in outcome after renal transplantation in addition to identifying factors associated with both favorable and poor outcomes. The registry has served to document and influence practice patterns, clinical outcomes, and changing trends in renal transplantation.
References
- 1 Stablein DM, Tejani A. Five-year patient and graft survival in North American children: A report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int Suppl 1993: 43: S16–21.
- 2 Tejani A, Sullivan EK, Fine RN, Harmon W, Alexander S. Steady improvement in renal allograft survival among North American children: A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study. Kidney Int 1995: 48: 551–553.
- 3 Salvatierra O, Alfrey E, Tanney DC, et al. Superior outcomes in pediatric renal transplantation. Arch Surg 1997: 132: 842–847.
- 4 Tejani A, Sullivan EK. Factors that impact on the outcome of second renal transplants in children. Transplantation 1996: 62: 606–611.
- 5 Tejani A, Stablein DM, Donaldson L, et al. Steady improvement in short-term graft survival of pediatric renal transplants: The NAPRTCS experience. Clin Transplant 1999: 95–110.
- 6 Elshihabi I, Chavers B, Donaldson L, Emmett L, Tejani A. Continuing improvement in cadaver donor graft survival in North American children: The 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000: 4: 235–246.
- 7 Mcdonald R, Donaldson L, Emmett L, Tejani A. A decade of living donor transplantation in North American children: The 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000: 4: 221–234.
- 8 Alexander SR, Arbus GS, Butt KM, et al. The 1989 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1990: 4: 542–553.
- 9 Mcdonald RA, Smith JM, Stablein D, Harmon WE. Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: A NAPRTCS report. Pediatr Transplant 2003: 7: 204–208.
- 10 Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992: 2: S258–263.
- 11 Baum MA, Ho M, Stablein D, Alexander SR. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant 2002: 6: 488–492.
- 12 Quan A, Sullivan EK, Alexander SR. Recurrence of hemolytic uremic syndrome after renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 2001: 72: 742–745.
- 13 Harmon WE, Stablein D, Alexander SR, Tejani A. Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1991: 51: 406–412.
- 14 Harmon WE, Alexander SR, Tejani A, Stablein D. The effect of donor age on graft survival in pediatric cadaver renal transplant recipients–a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1992: 54: 232–237.
- 15 Singh A, Stablein D, Tejani A. Risk factors for vascular thrombosis in pediatric renal transplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997: 63: 1263–1267.
- 16 Smith JM, Stablein D, Singh A, Harmon W, Mcdonald RA. Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists: A report of the NAPRTCS. Am J Transplant 2006: 6: 585–588.
- 17 Smith JM, Ho PL, Mcdonald RA. Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002: 6: 493–499.
- 18 Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001: 59: 328–333.
- 19 Feld LG, Stablein D, Fivush B, Harmon W, Tejani A. Renal transplantation in children from 1987-1996: The 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 1997: 1: 146–162.
- 20 Benfield MR, Mcdonald R, Sullivan EK, Stablein DM, Tejani A. The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999: 3: 152–167.
- 21 Arbus GS, Sullivan EK, Tejani A. Hospitalization in children during the first year after kidney transplantation. Kidney Int Suppl 1993: 43: S83–S86.
- 22 Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 2004: 4: 384–389.
- 23 Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE. Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001: 71: 1065–1068.
- 24 Dharnidharka VR, Tejani AH, HO PL, Harmon WE. Post-transplant lymphoproliferative disorder in the United States: Young Caucasian males are at highest risk. Am J Transplant 2002: 2: 993–998.
- 25 Dharnidharka VR, Ho PL, Stablein DM, Harmon WE, Tejani AH. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002: 6: 396–399.
- 26 Harmon WE, Sullivan EK. Cyclosporine dosing and its relationship to outcome in pediatric renal transplantation. Kidney Int Suppl 1993: 43: S50–S55.
- 27 Tejani A, Sullivan EK. Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: A report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1996: 7: 550–555.
- 28 Tejani AH, Stablein DM, Sullivan EK, et al. The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late acute rejections in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1998: 2: 318–324.
- 29 Benfield MR, Stablein D, Tejani A. Trends in immunosuppressive therapy: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999: 3: 27–32.
- 30 Smith JM, Nemeth TL, Mcdonald RA. Current immunosuppressive agents: Efficacy, side effects, and utilization. Pediatr Clin North Am 2003: 50: 1283–1300.
- 31 Ojogho O, Sahney S, Cutler D, et al. Mycophenolate mofetil in pediatric renal transplantation: Non-induction vs. induction with basiliximab. Pediatr Transplant 2005: 9: 80–83.
- 32 Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study. Pediatr Transplant 2003: 7: 217–222.
- 33 Brouhard BH, Donaldson LA, Lawry KW, et al. Cognitive functioning in children on dialysis and post-transplantation. Pediatr Transplant 2000: 4: 261–267.
- 34 Fine RN, Ho M, Tejani A. The contribution of renal transplantation to final adult height: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 2001: 16: 951–956.
- 35 Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E. Recombinant human growth hormone post-renal transplantation in children: A randomized controlled study of the NAPRTCS. Kidney Int 2002: 62: 688–696.
- 36 Tejani A, Sullivan K. Long-term follow-up of growth in children post-transplantation. Kidney Int Suppl 1993: 43: S56–S58.
- 37 Fine RN, Stablein DM, Tejani A. Do children exhibit catch-up growth post transplant: North American Pediatric Renal Transplant Cooperative Study special study. Pediatr Nephrol 1995: 9: S66–68.
- 38 Fine RN. Growth post renal-transplantation in children: Lessons from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1997: 1: 85–89.
- 39 Jabs K, Sullivan EK, Avner ED, Harmon WE. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1996: 61: 31–36.
- 40 Fine RN, Sullivan EK, Kuntze J, Blethen S, Kohaut E. The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients. J Pediatr 2000: 136: 376–382.
- 41 Fine RN, Stablein D. Long-term use of recombinant human growth hormone in pediatric allograft recipients: A report of the NAPRTCS Transplant Registry. Pediatr Nephrol 2005: 20: 404–408.
- 42 Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13–21.
Citing Literature
